Determination of zolpidem, a new sleep-inducing agent, and its metabolites in biological fluids: pharmacokinetics, drug metabolism and overdosing investigations in humans.
For the determination of zolpidem, a new sleep inducer, and its metabolites in human plasma and urine, three methods were developed that are suitable for pharmacokinetics, drug metabolism and overdosing investigations. The methods used for pharmacokinetic and drug metabolism studies are based on column-switching high-performance liquid chromatography; they do not require any sample manipulation because the plasma or diluted urine is injected into a pre-column where clean-up and preconcentration take place. The analytes are transferred by valve-switching to the C18 analytical column for chromatography. To investigate overdose cases, urine samples only are used: the method is simple, because the diluted urine can be injected directly into the analytical column (phenyl type). This allows the identification and quantification of the principal urinary metabolite of zolpidem, the unchanged drug being practically undetectable. All the methods use fluorescence detection, which affords high sensitivity and selectivity. It is necessary to use a method capable of the determination of metabolites even if these are apparently pharmacologically inactive, because in different physiopathological populations the qualitative and quantitative metabolic profiles of zolpidem could be different. The method designed for the investigation of (accidental or deliberate) overdose cases is, as required on such occasions, simple and rapid, with good selectivity with respect to commonly prescribed psychotropic drugs.
Ascalone
V
V
Synthélabo Recherche (L.E.R.S.), Department of Clinical Research, Limito, Italy.
Flaminio
L
L
Guinebault
P
P
Thénot
J P
JP
Morselli
P L
PL
D002851:Chromatography, High Pressure Liquid / Q000295:instrumentation / Q000379:methods*; D062787:Drug Overdose; D006801:Humans; D006993:Hypnotics and Sedatives / Q000032:analysis* / Q000378:metabolism / Q000493:pharmacokinetics / Q000506:poisoning; D011725:Pyridines / Q000032:analysis* / Q000378:metabolism / Q000493:pharmacokinetics / Q000506:poisoning; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013050:Spectrometry, Fluorescence; D000077334:Zolpidem
D006993:Hypnotics and Sedatives; D011725:Pyridines; D000077334:Zolpidem